These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 16445801

  • 1. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data.
    Black RJ, Gavin AT.
    Br J Dermatol; 2006 Mar; 154(3):566-7. PubMed ID: 16445801
    [No Abstract] [Full Text] [Related]

  • 2. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
    Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J.
    Br J Dermatol; 2005 Apr; 152(4):755-7. PubMed ID: 15840109
    [Abstract] [Full Text] [Related]

  • 3. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
    Jo SJ, Kwon HH, Choi MR, Youn JI.
    Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
    [Abstract] [Full Text] [Related]

  • 4. [Indications for UV-B irradiation].
    Hönigsmann H.
    Hautarzt; 1993 Aug; 44(8):545. PubMed ID: 8376111
    [No Abstract] [Full Text] [Related]

  • 5. [Cancerogenic role of narrow-spectrum UVB phototherapy].
    Guillaume JC.
    Ann Dermatol Venereol; 2000 Oct; 127(10):873-8. PubMed ID: 11185638
    [No Abstract] [Full Text] [Related]

  • 6. The challenge of follow-up in narrowband ultraviolet B phototherapy.
    Diffey BL, Farr PM.
    Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The dark side of the light: Phototherapy adverse effects.
    Valejo Coelho MM, Apetato M.
    Clin Dermatol; 2016 Aug; 34(5):556-62. PubMed ID: 27638433
    [Abstract] [Full Text] [Related]

  • 12. An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996).
    Br J Dermatol; 1997 Sep; 137(3):327-30. PubMed ID: 9349324
    [No Abstract] [Full Text] [Related]

  • 13. Cancer risk associated with therapeutic irradiation of skin.
    Burns FJ.
    Arch Dermatol; 1989 Jul; 125(7):979-81. PubMed ID: 2662913
    [No Abstract] [Full Text] [Related]

  • 14. Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy.
    Diffey BL.
    Br J Dermatol; 2003 Aug; 149(2):428-30. PubMed ID: 12932263
    [No Abstract] [Full Text] [Related]

  • 15. [Adverse effects of ultraviolet light therapy].
    Marks JM.
    Dent Cadmos; 1983 Apr; 51(4):43-8. PubMed ID: 6590323
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. To UVB or not to UVB?
    Swanbeck G.
    Photodermatol; 1984 Feb; 1(1):1-4. PubMed ID: 6531276
    [No Abstract] [Full Text] [Related]

  • 18. Validation of a semiautomated method of minimal erythema dose testing for narrowband ultraviolet B phototherapy.
    Otman SG, Edwards C, Gambles B, Anstey AV.
    Br J Dermatol; 2006 Aug; 155(2):416-21. PubMed ID: 16882183
    [Abstract] [Full Text] [Related]

  • 19. [Cancer and TL-01 UVB therapy, the same delusion as PUVA twenty years ago?].
    Revuz J.
    Ann Dermatol Venereol; 2004 May; 131(5):429-31. PubMed ID: 15235528
    [No Abstract] [Full Text] [Related]

  • 20. Narrow-band TL-01 phototherapy or PUVA? That is the question!
    Ortonne JP.
    J Dermatolog Treat; 2001 Jun; 12(2):67. PubMed ID: 12243660
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.